To investigate the temporal and causal relationships of structural changes in the brain in patients with schizophrenia.
Purpose:
To investigate the temporal and causal relationships of structural changes in the brain in patients with schizophrenia.
Materials and Methods:
T1-weighted magnetic resonance (MR) images of 97 patients with schizophrenia (29 women; mean 6 standard deviation age, 41 years 6 11.5; range, 16-66 years; illness duration, 16.3 years 6 10.9; range, 0-50 years) and 126 age-and sex-matched (38 years 6 14.9; range, 18-68 years; 42 women) healthy control subjects were evaluated. The causal network of structural covariance was used to assess the causal relationships of structural changes in patients with schizophrenia. This was accomplished by applying Granger causality analysis to the morphometric T1-weighted images ranked according to duration of disease.
Results:
With greater disease duration, reduction in gray matter volume began in the thalamus and progressed to the frontal lobe, and then to the temporal and occipital cortices as well and the cerebellum (P , .00001, false discovery rate corrected). The thalamus was shown to be the primary hub of the directional network and exhibited positive causal effects on the frontal, temporal, and occipital regions as well as on the cerebellum (P , .05, false discovery rate corrected). The frontal regions, which were identified to be transitional points, projected causal effects to the occipital lobe, temporal regions, and the cerebellum and received causal effects from the thalamus (P , .05, false discovery rate corrected).
Conclusion:
Schizophrenia shows progression of gray matter abnormalities over time, with the thalamus as the primary hub and the frontal regions as prominent nodes.
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To exclude the potential effect of similar genetic backgrounds, history of a psychiatric disorder in a first-or second-degree relative was an additional exclusion criterion for healthy control subjects. All patients were taking medication (eg, To evaluate the effects of various antipsychotic drugs, we used a standardized quantitative formula for each antipsychotic medication to determine equivalents to chlorpromazine (14) . The chlorpromazine equivalent dose of the antipsychotics was 324.5 mg per day 6 157.1. A sample of 126 healthy control subjects (84 men and 42 women; age, 38 years 6 14.9), matched to the patient group according to age and sex was also recruited in this study. The healthy control subjects were also matched with the patients with SZ in handedness (one left-handed and 125 right-handed healthy control subjects, three left-handed and 94 right-handed patients with SZ; P = .20, x 2 test) and
Granger causality (GC) analysis is another common technique that can allow delineation of information flow through detection of whether neural activity in one region precedes and allows prediction of the activity in another region. GC analysis is widely used in functional time-series data analysis for several neuropsychiatric disorders such as SZ (9, 10) , social anxiety disorder (11) , and epilepsy (12) . When morphometric data are ranked according to progression, information such as disease duration, and given temporal information, GC analysis can be applied to these sequenced data to assess the causal relationships of structural alterations among brain regions. This approach, named causal structural covariance network (CaSCN) analysis, was used in a recent epilepsy study (13) . Therefore, we hypothesized that the CaSCN could be used to characterize the progressive alterations of the structural brain network in patients with SZ. In our study, we aimed to investigate the progressive profiles of the structural network throughout the duration of the illness and to further evaluate the causal effect of structural changes in patients with SZ by using the CaSCN.
Materials and Methods

Participants
The study was approved by the Ethics Committee of the Clinical Hospital of Chengdu Brain Science Institute (Chengdu Mental Health Center), and all subjects provided written informed consent after they were given a complete description of the study. Ninetyseven patients with SZ (68 men; mean 6 standard deviation age, 41.0 years 6 11.5; range, 16-66 years; mean illness duration, 16.3 years 6 10.9; range, 0-50 years) were recruited from the Clinical Hospital of Chengdu Brain Science Institute. Each patient was diagnosed on the basis of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Subjects with a history of brain injuries, substancerelated disorders, and major medical or neurologic disorders were excluded. 
Implication for Patient Care
n The thalamus is implicated as the primary hub of progressive gray matter abnormalities that subsequently progress to other regions of the brain.
S chizophrenia (SZ) is a common psychiatric disorder characterized by a multidimensional psychotic syndrome (1) . Morphometric studies have revealed gray matter (GM) volume atrophy in subcortical regions of the thalamus and basal ganglia and cortical GM including the frontal, temporal, and occipital lobes as well as the cerebellum (2, 3) , indicating the importance of multiregional abnormalities in the pathologic mechanism of SZ. It is currently hypothesized that as a developmental disorder, SZ shows progressive impairments in cerebral morphology and connectivity (4) . Therefore, investigating the interregional relationship of progressive brain damage is necessary to understand the pathologic deviations of neurodevelopment in patients with SZ.
Structural covariance network (SCN) techniques have been introduced to quantitatively determine whether a morphometric change in one region correlates with changes in other regions (5, 6) . SCN has been applied to investigate the network characteristics and the structural covariance connectivity in multiple diseases including SZ (7) . Studies have demonstrated abnormal segregation among the prefrontal cortex and somatosensory and occipital regions with use of the SCN (8) . Authors of these studies have effectively mapped the topologic patterns of concomitant changes among brain regions and coordinated developmental processes of brain abnormalities in patients with SZ. However, one limitation of the SCN method is that it involves correlation analysis (zero time-lagged correlation) to measure the synchronization; therefore, it cannot allow quantification of the possible causal relationships between different brain regions (ie, whether the damage in one region precedes that in another). discovery rate corrected). Ten twosample t tests were performed; thus we applied a strict threshold P value of less than .00001 after false discovery rate correction for each t map to account for the increase in the probability of false-positive results; the threshold corresponds to a P value of less than .0001 after Bonferroni correction. To ensure that any differences were not due to an arbitrary strategy, we also categorized all patients into six subgroups according to duration of disease (0-5 years, 5-10 years, 10-15 years, 5-20 years, 20-25 years, and . 25 years) to further verify the results. Sex and age were regressed as covariates in these analyses. In addition, to investigate the relationship between atrophy magnitude and SZ duration, voxel-wise Spearman correlation analysis was performed (P , .05, false discovery rate corrected).
Mapping Causal Effect of GM Atrophy Pattern in SZ by Using Seed-based CaSCN
The analysis pipeline for the CaSCN was similar to that used in the original study by Zhang and colleagues (13) and is only briefly described here. The GM volume data of all patients were sequenced according to the ranks of the SZ duration from low to high. This data sequencing was analogous to time-series information for characterizing the progressive property of SZ on the basis of cross-sectional data. Subsequently, similar to GC analysis applied in functional MR imaging data analysis, the pseudo-time series was used to construct seed-based CaSCN. The seed region was selected from the previously mentioned voxel-based morphometric analysis. Signed-path coefficient GC analysis implemented with an MR imaging toolkit (REST; http:// www.restfmri.net) was performed on a voxel-wise basis for all the voxels in the mask of the brain areas with reduced GM volume. The signed-path coefficient GC analysis has been used previously to investigate directed influences between two regions and has been used in patients with SZ undergoing functional MR imaging (9, 19) . Similarly, the CaSCN could allow assessment of the causal effect of GM volume alteration cm; matrix size, 256 3 256; section thickness, 1 mm (no gap). A functional MR imaging sequence was also performed but not used in our study.
Data Preprocessing
High-spatial-resolution T1-weighted MR imaging data were processed with standard voxel-based morphometry by using the Computational Anatomy Toolbox (CAT12; http://dbm.neuro.unijena.de/cat12/) in statistical parametric mapping software (SPM12; http:// www.fil.ion.ucl.ac.uk/spm/). First, all images were checked for artifacts and reoriented to adjust image origins at the anterior commissure. Second, T1-weighted images were normalized to Montreal Neurologic Institute space; segmented into GM, white matter, and cerebrospinal areas; and resampled to a volume image resolution of 2 3 2 3 2 mm . After the data quality and sample homogeneity were checked, the segmented GM images were smoothed by using an 8-mm full width at half maximum Gaussian kernel. Finally, the GM optimal threshold mask, created with data from all subjects, was applied to eliminate non-GM voxels (18) . The generated smoothed GM images were used as the GM volume for subsequent group comparisons.
Voxel-based Morphometric Analysis: Overall and Stage-specific Atrophy Patterns in SZ To estimate the overall GM volume alterations in patients with SZ, the two sample t test implemented in SPM12 was performed between the GM images of SZ and healthy control subject groups (P , .00001, false discovery rate corrected). Subsequently, to map the progressive patterns of GM volume atrophy in the SZ, we used stage-specific procedures that have been used in previous works (13) . All patients were categorized into three subgroups according to the progressive stage of SZ duration (stage 1, 0-10 years; stage 2, 11-20 years; and stage 3, . 20 years). Then, GM volume images of each subgroup were compared with those of healthy control subjects by using a two-sample t test (P , .00001, false years of education (SZ, 11.8 years 6 3.1; healthy control subjects, 10.9 years 6 3.4; P = .08, two sample t test). The magnetic resonance (MR) imaging anatomic images were evaluated by two experienced radiologists (C.L. and W.Y., each with more than 10 years of experience in radiology) to exclude subjects with gross brain abnormalities. Four patients with SZ and one healthy control subject were excluded because they were unable to complete MR imaging. Some of the patients were part of previous studies (9, (15) (16) (17) . Twenty-eight of the 97 patients were included in a prior study in which the authors identified abnormal functional integration in the basal ganglia network by using spatial independent component analysis (15) . The same 28 patients were also included in a prior article in which the authors found functional disconnection between the visual cortex and the sensorimotor cortex by using functional connectivity density analysis (16) . Forty-six of the 97 patients were previously included in a prior article in which authors demonstrated dysfunction in the insula with data-driven clustering and functional connectivity analysis (17) . Sixty-nine of the 97 patients were included in a prior article in which the authors identified an altered hippocampus-cerebellumcortical circuit with a combination of local consistency analysis and GC analysis (9) . All of these previous studies were investigations of brain dysfunctions in which resting-state functional MR imaging data were used, whereas our study was focused on progressive brain morphologic abnormalities in which structural MR imaging data were used (T1-weighted images). 
Image Acquisition
Results
GM Atrophy Pattern
Compared with the healthy control subjects, the patients with SZ showed reduced GM volume in the thalamus, basal ganglia, frontal lobe, insula, pre-and postcentral gyrus, bilateral temporal gyrus, occipital cortex, and cerebellum (Fig 1) . No region with increased GM volume was observed in the SZ group. Detailed regions are provided in Table E1 (online). Correlation analysis between reduced GM volume and SZ duration demonstrated that longer disease duration was related to lower GM volume. These areas included the bilateral frontal lobe, middle cingulate gyrus, left inferior parietal lobule, left postcentral gyrus, right obtained from CaSCN analysis, we also calculated an ROI-to-ROI GC analysis, as originally proposed by Zhang and colleagues (13) . The signed-path coefficient GC analysis was performed to construct an ROI-wise causal network that characterized causal relationships among ROIs. To maintain consistency with the voxel-wise CaSCN analysis, the same threshold was set at a GC value of greater than 0.16. The binary (weighted) "out-degree" and "in-degree" values (in-degree value = the number of head ends adjacent to a node, out-degree value = number of tail ends adjacent to a node) of each ROI were computed separately. The binary (weighted) in-degree value of an ROI represents the sum of the number (strength) of paths projecting to the ROI. The binary (weighted) out-degree value of a node refers to the sum of the number (strength) of paths projecting to other nodes. In addition, the outin degree was also calculated as the of a region on the other regions. As the seed exhibited the reduction of GM volume in SZ, a positive Granger causality (GC) value indicated that the same GM volume alteration (reduced) in the regions lagged behind the seed atrophy, which may suggest the reduction is driven by the seed. A negative GC value denoted that regions with an opposite alteration (increased) lagged behind the seed atrophy, which may imply a compensatory effect. Sex, age, total intracranial volume, and time interval between two pseudo-time points were regressed as covariates in conducting CaSCN analysis. To present statistical significance, the GC map was transformed to a z score map and the threshold was presented at a z score of greater than 2.3 and a GC value of greater than 0.16. This corresponded to a P value of .05, false discovery rate corrected (13) .
To further investigate the causal effect among the regions of interest (ROI) 
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Figure 3
Figure 3: Causal networks show causal effects of gray matter atrophy pattern in patients with schizophrenia (SZ). Causal networks were constructed by applying Granger causality (GC) analysis to sequenced morphometric data according to the ranks of SZ duration from low to high. The thalamus (Montreal Neurologic Institute coordinates: 1, 213, 10) was used as the seed region on the basis of voxel-based morphometric analysis. Considering the reduction in the gray matter volume of thalamus in patients with SZ, regions with positive GC values indicate the same gray matter volume alteration (reduction) lagged behind thalamus atrophy, which may suggest that it is driven by the thalamus. GC values were transformed to z values.
lingual gyrus, and bilateral putamen as well as the cerebellum (Table E2 and Fig E1 [online] ). (Fig 2) . Detailed results are provided in Table E3 and Figure E2 (online). We further evaluated the relationship between GM volume reductions in each stage and disease duration. We found that atrophy in the medial prefrontal cortex and left orbitofrontal cortex was negatively correlated with disease duration at stage 1. The GM volume reduction in the postcentral gyrus was negatively associated with disease duration at stage 2 (Table E4 and Fig E3  [online] ). At stage 3, disease duration was not correlated with GM volume alterations in any region (all P values . .05). With the use of another categorized strategy in which patients were divided into six subgroups according to disease (0-5 years, 5-10 years, 10-15 years, 15-20 years, 20-25 years, and . 25 years) similar alteration patterns were exhibited (compare Fig 2, B) .
Stage-specific Atrophy Patterns in
Mapping Causal Effects of GM Atrophy Pattern in Patients with SZ
To characterize the causal effect of progressive GM volume atrophy in patients with SZ, the CaSCN was constructed with the thalamus as the seed, since it was reduced in the first stage. The thalamus region (Montreal Neurologic Institute coordinates: 1, 213, 10) was selected from a two-sample t test of a whole-brain voxel-based morphometric comparison among all patients and healthy control subjects. CaSCN results demonstrated positive GC from the seed in the thalamus to the frontal lobe, cingulate cortex, insula, pre-and postcentral gyrus, temporal-parietal junction,
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Jiang et al received more causal effects from other nodes and were identified as the causal targets. The pattern of the CaSCN was generally in line with results of the stage-specific comparative analysis. Changes in brain structure over time are best evaluated in longitudinal studies (20) . However, results from this work suggest the potential for assessing temporal changes in the structure of the brain by applying GC analysis to morphometric data classified according to illness duration. In spite of antipsychotic medication or epiphenomena related to the disease (21), illness duration can be used as a surrogate parameter for describing the progression of SZ. A pseudo-time series and lifespan information of illness progression may be generated by incorporating information on disease duration. The CaSCN revealed that structural changes in one region precede and allow prediction of the change in another region in relationship to the duration of illness (ie, a potential causal effect). Consistent points. The nodes in the temporal lobe, occipital cortex, and the cerebellum received more causal effect from other nodes (ie, in-degree hubs), which were identified as the causal targets.
Discussion
By using T1-weighted structural data, we evaluated the causal relationship between brain regions with progressive morphometric alterations in patients with SZ by using the CaSCN. Duration of illness was associated with GM volume reductions progressing from the thalamus to the frontal lobe, and then to temporal, occipital, and cerebellar regions. A directional network demonstrated that the thalamus was its hub; changes in the thalamus were potentially causally related to all other nodes. The frontal nodes, which were identified to be transition points, received causal effects from the thalamus and projected causal effects to other regions. The temporal, occipital, and cerebellar regions angular and temporal gyrus, hippocampus, fusiform, and cerebellum (Fig 3 and Table 1 ). This indicates that the thalamus may be the hub of the directional network in terms of out-degree values, and may exhibit positive causal effects to other regions, thus potentially exerting a damaging effect to other regions. These regions were extracted to use for the ROI-to-ROI CaSCN analysis. No negative GC was observed from the seed to other regions. Also, no causal effects from other regions to the seed in the thalamus were found.
The ROI-to-ROI results exhibited a directional network that revealed an interregional causal relationship (Fig 4) . The frontal nodes including the dorsolateral prefrontal cortex, orbitofrontal cortex, ventromedial prefrontal cortex, and middle cingulate cortex mainly projected causal effects to the occipital lobe, temporal regions, and the cerebellum (ie, out-degree hubs) and received causal effects from the thalamus, which were identified to be transition Note.-Numbers followed by the same lowercase letter (a-f) mean that these regions shared the same clusters. CaSCN = causal structural covariance network.
NEURORADIOLOGY: Assessment of Gray Matter in Schizophrenia with Causal Network Analysis Jiang et al
with traditional methods such as stagespecific comparisons (22) , The CaSCN captured the reduction in GM from the thalamus to other regions. These results further demonstrated that CaSCN analysis could be an effective method to explore interregional covariance of structural changes in patients with SZ. Consistent with results of a previous longitudinal study (22) , in this study we found progressive GM reductions during particular stages of illness. The illness duration of SZ was associated with GM atrophy progressing from the thalamus to the frontal lobe and then to the temporal lobe, occipital cortices, and the cerebellum. This progressive atrophy pattern in these regions has been observed in patients with a first-episode of or chronic SZ (23) (24) (25) (26) (27) (28) . In particular stages of illness, lower GM volume in the frontal lobe and the postcentral gyrus was linked to longer disease duration, consistent with results from previous studies (22, 29) . This progressive atrophy may reach a maximum effect after long duration of illness (. 20 years). In addition, authors of prior studies (30, 31) have found that progressive GM loss in patients with SZ was associated with prominent negative symptoms and cognitive impairment. Our findings provide further evidence of progressive GM reductions during different stages of illness duration and further demonstrated an interregional causal relationship.
In our study, the thalamus, as the hub of the directional network, demonstrated positive causal effects on frontal areas, the temporal lobe, occipital regions, and the cerebellum. The thalamus is an essential node that is engaged in the bidirectional flow of neuronal signals between different cortical areas and subcortical regions and has been linked to the processing of cognition and emotion, which are impaired in patients with SZ (32, 33) . The positive causal value might implicate that regional GM volume reduction of the thalamus precedes that of the other regions. The thalamus connects to different cortical areas as well as the cerebellum (34); GM loss in the thalamus may consecutively lead to neuronal A, Bivariate signed-path coefficient Granger causality analysis was performed to construct an ROI-wise causal network to characterize causal relationships among ROIs. B, The binary (weighted) out-and in-degree value of each ROI was computed separately. In detail, the binary (weighted) in-degree value of a ROI represents the sum of the number (strength) of paths that project to itself. The binary (weighted) out-degree value of a node refers to the sum of the number (strength) of paths that project to other nodes. In addition, the out-in degree value was also calculated as the subtraction between out-degree and in-degree values to identify the causal targets or causal source levels. AG = angular gyrus, CB6 = cerebellum 6, DLPFC = dorsal lateral prefrontal cortex, DMPFC = dorsal medial prefrontal cortex, Fus = fusiform, HIP = hippocampus, INS = insula, ITG = inferior temporal gyrus, L = left, LING = lingual gyrus, MCC = middle cingulate cortex, MTG = middle temporal gyrus, OFC = orbital frontal cortex, PCC = posterior cingulate cortex, PoC = postcentral gyrus, R = right, SFG = superior frontal gyrus; TPJ = temporoparietal junction, VMPFC = ventral medial prefrontal cortex.
The interregional causal effect of structural changes and illness progression in patients with SZ was assessed by using the CaSCN. With greater duration of SZ, GM volume reductions extended from the thalamus to the frontal lobe, and then to the temporal lobe, occipital cortices, and the cerebellum. CaSCN analysis results suggest that the thalamus is the hub of the directional network; the frontal nodes projected causal effect to the occipital lobe, temporal regions, and cerebellum and received the causal effect from the thalamus. These results imply a hierarchy of structural brain damage and an important role of the thalamus and frontal lobe in disease progression. Our work provides further evidence to suggest that SZ is associated with progressive GM abnormalities. damage in other regions. Several studies have provided evidence of the crucial role of the frontal cortex in the pathology of SZ and reported that a reduction of GM volume in the prefrontal lobe was associated with cognitive and emotional dysfunction (35) . In addition, diffusion-tensor imaging indicated an aberrant frontal-thalamic structural connectivity in patients with SZ (36) . In a study (2) in which structural MR imaging and resting-state functional MR imaging were used, authors found that the causal connectivity of the frontalthalamic circuit might be affected by structural deficits in patients with SZ. Overall, our study results illustrated a potential causal relationship from the thalamus and frontal lobe to further regions with GM atrophy, which might indicate the progressive pathologic process of structural damage in SZ.
Our study had several limitations. First, the underlying physiologic mechanism of disease progression still remains unclear. In addition, temporally organized data do not directly reflect the real temporal sequence of illness progression. Thus, longitudinal studies must be performed to further clarify the causal relationship between structural deficits. Second, although age was regressed as a covariate in CaSCN analysis, its confounding effect on the structural images cannot be excluded. The causal relationships between structural alterations and illness course should be interpreted cautiously. Third, all patients received antipsychotic medication. Therefore, findings may have been confounded by the treatment regimen, antipsychotic therapy, or epiphenomena related to the illness. Fourth, illness duration was used for describing the progression of SZ. Other clinical variables such as severity of illness or response to treatment, which may be related to brain alterations, must be considered in the future (22) . Furthermore, stage-specific comparisons were performed by dividing all patients into several subgroups according to stage of illness duration, which was an arbitrary strategy. Finally, the validation of CaSCN analysis results should be verified through replication samples.
